NYLT
BIIB icon

New York Life Trust’s Biogen BIIB Stock Holding History

New York Life Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-148
Closed -$45K – 258
2015
Q4 		$45K Sell
148
-305
-67% -$87.6K 0.19% 147
2015
Q3 		$132K Buy
453
+59
+15% +$19.5K 0.59% 48
2015
Q2 		$159K Sell
394
-161
-29% -$64.6K 0.66% 44
2015
Q1 		$234K Buy
555
+21
+4% +$8.28K 0.93% 25
2014
Q4 		$181K Buy
534
+414
+345% +$134K 0.71% 40
2014
Q3 		$40K Buy
+120
New +$39.6K 0.17% 156
2014
Q2 		– Sell
-51
Closed -$16K – 195
2014
Q1 		$16K Sell
51
-11
-18% -$3.49K 0.07% 170
2013
Q4 		$17K Sell
62
-236
-79% -$61K 0.08% 173
2013
Q3 		$72K Sell
298
-97
-25% -$21.7K 0.36% 116
2013
Q2 		$85K Buy
+395
New +$84.4K 0.39% 101

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

New York Life Trust's BIIB Position: Q1 2016 in Review

New York Life Trust sold out of Biogen (BIIB) in Q1 2016, closing a stake of 148 shares — an estimated $45K sold.

New York Life Trust first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $234K in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • New York Life Trust reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • New York Life Trust sold 148 Biogen shares in Q1 2016, an estimated $45K.
  • New York Life Trust first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
  • New York Life Trust's Biogen position peaked at $234K in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on New York Life Trust's 13F filing for Q1 2016, filed 16 May 2016.